BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

GlySure Appoints Heidi Hausner as U.S. Director of Clinical Affairs


8/1/2012 10:10:47 AM

ABINGDON, England, August 1, 2012 /PRNewswire/ --

GlySure Limited, developer of in-hospital continuous glucose monitoring (CGM) systems, today announced the appointment of Heidi Hausner, RN as its U.S. Director of Clinical Affairs. In this newly established position, Hausner will lead U.S. clinical regulatory trials for GlySure's CGM technology and support the company's clinical trials in Europe.

Hausner has more than 25 years of experience in both the manufacturing sector directing all aspects of medical device clinical trials, as well as sales field training and project management and in the clinical setting as a critical care operating room (OR) nurse.

Hausner most recently served as Senior Clinical Research Manager for Synthes, a market leader in trauma, cranio/maxillofacial and spine industries (now part of Johnson & Johnson), where she led the teams responsible for clinical investigations in both pre- and post-market environments.

"Hausner's strong background in clinical care and medical device trial management will be an invaluable asset as we embark on our U.S. and European trials this fall," said GlySure CEO Chris Jones. "Her experience both at the patient bedside and behind the scenes in product development and sales training will help drive the development of technology that meets the clinical demand for CGM while improving the efficiency and reducing the cost of care."

Hausner holds a Master of Science degree in Quality Assurance and Regulatory Affairs and a certificate in Clinical Trial Management from Temple University School of Pharmacy, a Bachelor of Health Science in Management degree from Gwynedd Mercy College and a diploma in Nursing from St. Luke's Hospital School of Nursing.

About GlySure:

GlySure has developed a continuous intravascular glucose monitoring system using a proprietary optical fluorescence sensor to meet the $2B+ worldwide demand for implementation of Tight Glycemic Control (TGC) in the hospital Intensive Care Unit (ICU). The company has demonstrated through ICU testing highly accurate sensors which can provide continuous glucose readings throughout the length of a patient's stay in the ICU. GlySure was founded in 2006, it is based in Abingdon, Oxfordshire, England and it has 20 employees. The company's products are not approved for use in the U.S. or Europe. http://www.glysure.com

Company Contact:Chris Jones, CEO, GlySure, Tel: +44(0)1235-462-870, cjones@glysure.com
Media Contact:Bruce Dodworth, Sea Glass PR, Tel: +44(0)1780-769069, bruce@seaglasspr.com


SOURCE GlySure Limited



Read at BioSpace.com

GlySure
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES